First human trial launches for Dual-Virus HFMD vaccine
NCT ID NCT07326878
Summary
This early-stage study is testing a new vaccine designed to protect against Hand, Foot and Mouth Disease (HFMD), which commonly affects young children. Researchers will give the experimental vaccine or a placebo to 144 healthy volunteers aged 6 months to 59 years to check for safety issues and see if it triggers an immune response. The study will carefully monitor participants for side effects and measure antibody levels after two doses given one month apart.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAND, FOOT, AND MOUTH DISEASE (HFMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.